Laguna Beach, CA, United States of America

E Quinn Farnes

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Allergan, Inc.. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: E Quinn Farnes. Retrieved from https://idiyas.com/inventor/e-quinn-farnes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: E Quinn Farnes: Innovator in Pharmaceutical Formulations

Introduction

E Quinn Farnes is a notable inventor based in Laguna Beach, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of cyclosporin A. With a total of 3 patents to his name, Farnes continues to push the boundaries of innovation in his industry.

Latest Patents

Farnes' latest patents include methods of formulating cyclosporin A Form 2. These patents focus on the creation of suspensions of cyclosporin A Form 2, which are crucial for enhancing the efficacy and stability of this important pharmaceutical compound.

Career Highlights

Farnes is currently employed at Allergan, Inc., where he applies his expertise in pharmaceutical formulations. His work has been instrumental in advancing the company's product offerings and improving patient outcomes.

Collaborations

Throughout his career, Farnes has collaborated with esteemed colleagues such as Anuradha V Gore and Prem Swaroop Mohanty. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

E Quinn Farnes is a dedicated inventor whose work in pharmaceutical formulations has made a significant impact in the industry. His contributions continue to shape the future of medicine and improve the lives of patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…